These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 9650331

  • 1. Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma.
    Rodríguez-Cuevas S, López-Chavira A, Zepeda del Río G, Cuadra-García I, Fernández-Diez J.
    Arch Med Res; 1998; 29(2):155-8. PubMed ID: 9650331
    [Abstract] [Full Text] [Related]

  • 2. [Hypomelanosis of the skin and malignant melanoma (author's transl)].
    Ortonne JP, Gauthier Y, Guillet G, Gauthier O.
    Ann Dermatol Venereol; 1978 Dec; 105(12):1043-52. PubMed ID: 753117
    [Abstract] [Full Text] [Related]

  • 3. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R, Bril H, van der Loo EM, de Graaf PW.
    Ned Tijdschr Geneeskd; 2004 May 01; 148(18):884-8. PubMed ID: 15152391
    [Abstract] [Full Text] [Related]

  • 4. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.
    J Am Acad Dermatol; 2001 May 01; 44(5):762-6. PubMed ID: 11312421
    [Abstract] [Full Text] [Related]

  • 5. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V, Breuninger H, Garbe C, Moehrle M.
    Br J Dermatol; 2006 Feb 01; 154(2):310-8. PubMed ID: 16433802
    [Abstract] [Full Text] [Related]

  • 6. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F, Kurul S, Camlica H, Topuz E.
    Jpn J Clin Oncol; 2006 Dec 01; 36(12):794-9. PubMed ID: 17060409
    [Abstract] [Full Text] [Related]

  • 7. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA, Talamini R, Stanganelli I, Puddu P, Bono R, Argenziano G, Veronesi A, Trevisan G, Rabinovitz H, Soyer HP.
    Br J Dermatol; 2004 Jun 01; 150(6):1117-24. PubMed ID: 15214897
    [Abstract] [Full Text] [Related]

  • 8. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S, Kamo R, Harada T, Ishii M.
    Osaka City Med J; 2009 Jun 01; 55(1):35-52. PubMed ID: 19725433
    [Abstract] [Full Text] [Related]

  • 9. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.
    Ann Surg Oncol; 2008 Jan 01; 15(1):310-5. PubMed ID: 17987346
    [Abstract] [Full Text] [Related]

  • 10. [Melanoma in organ transplant patients].
    Lévêque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B, Hazan M, Schollhamer M, Aubin F, Dreno B, Daguin P, Chevrant-Breton J, Frances C, Bismuth MJ, Tanter Y, Lambert D.
    Ann Dermatol Venereol; 2000 Feb 01; 127(2):160-5. PubMed ID: 10739973
    [Abstract] [Full Text] [Related]

  • 11. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
    Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ.
    Ann Surg Oncol; 2006 Jul 01; 13(7):927-32. PubMed ID: 16788753
    [Abstract] [Full Text] [Related]

  • 12. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY, Tufaro AP, Manson PN.
    Ann Plast Surg; 2003 Jun 01; 50(6):601-6. PubMed ID: 12783009
    [Abstract] [Full Text] [Related]

  • 13. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A, Osinga J, Schwipper V, Schober O, Tilkorn H, Liebau J.
    Chirurg; 2003 Jul 01; 74(7):665-70. PubMed ID: 12883795
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M.
    Cancer; 2002 Feb 15; 94(4):1049-56. PubMed ID: 11920475
    [Abstract] [Full Text] [Related]

  • 16. [Feasibility and technical problems of sentinel node analysis in melanoma].
    Mebazaa A, Kerob D, Toubert ME, Verola O, Servant JM, Baccard M, Billotey C, Bustamante K, Vandici FO, Basset-Seguin N, Ollivaud L, Morel P, Lebbé C.
    Ann Chir Plast Esthet; 2007 Feb 15; 52(1):14-23. PubMed ID: 17141391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Melanoma in the elderly patient.
    Chang CK, Jacobs IA, Vizgirda VM, Salti GI.
    Arch Surg; 2003 Oct 15; 138(10):1135-8. PubMed ID: 14557133
    [Abstract] [Full Text] [Related]

  • 19. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB, Lee RJ, Prescott RJ, Doherty VR.
    Br J Dermatol; 2004 Mar 15; 150(3):523-30. PubMed ID: 15030337
    [Abstract] [Full Text] [Related]

  • 20. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
    Quinn MJ, Crotty KA, Thompson JF, Coates AS, O'Brien CJ, McCarthy WH.
    Cancer; 1998 Sep 15; 83(6):1128-35. PubMed ID: 9740077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.